Gad Berdugo has more than 30 years of experience across the global biotech sector, with a career spanning corporate and business development, company building, and U.S. capital markets. He has been closely involved in forming partnerships, raising growth capital, and scaling both private and public biotechnology companies.

He is currently Managing Partner at Explorium Capital LLC. Previously, he served as Co-Founder and CEO of EpiVax Oncology and held CBO roles at Editas Medicine and Nutcracker Therapeutics. He was previously Director and Life Sciences Sector Leader at Lazard, Asset Management Division and started his career at Abbott then Baxter Healthcare.

Mr. Berdugo received his B.Sc. with Honors in Biotechnology from Imperial College London, his M.Sc. in Biochemical Engineering from University College London and his M.B.A. from H.E.C. Paris.